RxDoctor Payments Data

Jennifer Vaz, MD

Gynecologic Oncology · Washington, DCNPI 1174987945

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,000 of the $1,514 with a category attached, or 66.1%. Intuitive Surgical accounts for 69.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,089 and has fallen 85.3% since, to $160 in 2025.

$1,514in general payments, 2019–2025

Across 20 payments — averaging $75.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • GSK$149
  • Merck$115
  • Novartis$74
  • Bayer$27
  • Myriad Genetic Laboratories, Inc.$25
  • plus $76 from 4 others

What the payments were for

  • Food & beverage$51434%
  • Education$1,00066%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecologic oncology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$408,256
Medicare patients
34
Services billed
20,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →